Raymond James Trust N.A. Trims Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Raymond James Trust N.A. lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 50,818 shares of the pharmacy operator’s stock after selling 2,020 shares during the quarter. Raymond James Trust N.A.’s holdings in Walgreens Boots Alliance were worth $455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of WBA. New Covenant Trust Company N.A. bought a new stake in shares of Walgreens Boots Alliance during the 1st quarter valued at $35,000. Iron Horse Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares during the period. Blue Trust Inc. lifted its position in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares in the last quarter. Continuum Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,020 shares during the period. Finally, Strategic Investment Solutions Inc. IL purchased a new stake in shares of Walgreens Boots Alliance during the second quarter worth about $34,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 3.6 %

Walgreens Boots Alliance stock opened at $8.73 on Wednesday. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $27.05. The business has a fifty day moving average of $9.13 and a two-hundred day moving average of $11.39. The firm has a market cap of $7.55 billion, a P/E ratio of -0.87, a P/E/G ratio of 1.14 and a beta of 0.69. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue was up 5.9% compared to the same quarter last year. During the same period last year, the firm earned $0.67 earnings per share. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.45%. The ex-dividend date of this dividend is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Morgan Stanley dropped their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Evercore ISI increased their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Finally, Jefferies Financial Group dropped their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.